Pangcatan, Baby N.
HRN: 21-58-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2022
AMPICILLIN 250MG (VIAL)
11/04/2022
11/10/2022
IV
215 Mg
Q6H
RAgt Positive COVID 19, Mild
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes